Enhanced Genomics extends Series A funding to USD $19 million to drive development of therapeutics pipeline
Enhanced Genomics (‘Enhanced’), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for…